Andrew Garazha

2.8k total citations · 1 hit paper
58 papers, 1.7k citations indexed

About

Andrew Garazha is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrew Garazha has authored 58 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 25 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrew Garazha's work include Cancer Genomics and Diagnostics (16 papers), Bioinformatics and Genomic Networks (13 papers) and Lung Cancer Treatments and Mutations (8 papers). Andrew Garazha is often cited by papers focused on Cancer Genomics and Diagnostics (16 papers), Bioinformatics and Genomic Networks (13 papers) and Lung Cancer Treatments and Mutations (8 papers). Andrew Garazha collaborates with scholars based in Russia, United States and Germany. Andrew Garazha's co-authors include Anton Buzdin, Maxim Sorokin, Nikolay Borisov, Marianna Zolotovskaia, Denis Kuzmin, Pieter Borger, Anna A. Emelianova, Nicolas Borisov, Maria Suntsova and Alex Zhavoronkov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and International Journal of Molecular Sciences.

In The Last Decade

Andrew Garazha

57 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs

2019 467 citations Marianna Zolotovskaia, Maxim Sorokin et al. profile →

Peers

Countries citing papers authored by Andrew Garazha

Since Specialization

Citations

This map shows the geographic impact of Andrew Garazha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Garazha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Garazha more than expected).

Fields of papers citing papers by Andrew Garazha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Garazha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Garazha. The network helps show where Andrew Garazha may publish in the future.

Co-authorship network of co-authors of Andrew Garazha

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Garazha. A scholar is included among the top collaborators of Andrew Garazha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Garazha. Andrew Garazha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospective trial of the Oncobox platform RNA sequencing bioinformatic analysis for personalized prescription of targeted drugs 2025 ·Computers in Biology and Medicine ·Maxim Sorokin, Andrew Garazha, (unknown), Victor Tkachev, Elena Poddubskaya, Нуршат Гайфуллин, (unknown), (unknown), Vitaliy B. Borisov, (unknown), (unknown), (unknown), (unknown), Alexey Moisseev, Anton Buzdin	0
2	Biomarkers of success of anti-PD-(L)1 immunotherapy for non-small cell lung cancer derived from RNA- and whole-exome sequencing: results of a prospective observational study on a cohort of 85 patients 2024 ·Frontiers in Immunology ·Elena Poddubskaya, (unknown), (unknown), (unknown), (unknown), Vladimir Lyadov, Andrew Garazha, Maxim Sorokin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
3	Distinct Traits of Structural and Regulatory Evolutional Conservation of Human Genes with Specific Focus on Major Cancer Molecular Pathways 2023 ·Cells ·Г. С. Захарова, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andrei Alimov, (unknown), (unknown), (unknown), (unknown), Victor Tkachev, Andrew Garazha, Marina Sekacheva, (unknown), Maxim Sorokin, Anton Buzdin, Marianna Zolotovskaia	1
4	Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways 2023 ·Cells ·Dmitri Kamashev, (unknown), Timofey Lebedev, Vladimir Prassolov, (unknown), (unknown), Нуршат Гайфуллин, Marina Sekacheva, Andrew Garazha, Elena Poddubskaya, Maxim Sorokin, Anton Buzdin	5
5	Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data 2022 ·BMC Cancer ·Maxim Sorokin, Marianna Zolotovskaia, Daniil Nikitin, Maria Suntsova, Elena Poddubskaya, (unknown), Andrew Garazha, Alexey Moisseev, Xinmin Li, Marina Sekacheva, (unknown), (unknown), Ye Wang, Anton Buzdin	9
6	Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas 2021 ·Cancers ·Marianna Zolotovskaia, Victor Tkachev, Maxim Sorokin, Andrew Garazha, Ella Kim, Sven Rainer Kantelhardt, (unknown), Alja Zottel, Neja Šamec, Denis Kuzmin, (unknown), Alexey Moisseev, Alf Giese, (unknown), Ivana Jovčevska, Anton Buzdin	12
7	Algorithmic Annotation of Functional Roles for Components of 3,044 Human Molecular Pathways 2021 ·Frontiers in Genetics ·Maxim Sorokin, Nicolas Borisov, Denis Kuzmin, (unknown), Marianna Zolotovskaia, Andrew Garazha, Anton Buzdin	38
8	Gene Expression Signature of Endometrial Samples from Women with and without Endometriosis 2021 ·Journal of Minimally Invasive Gynecology ·L.V. Adamyan, (unknown), A.A. Stepanian, Daniil Nikitin, Andrew Garazha, Maria Suntsova, Maxim Sorokin, Anton Buzdin	19
9	DNA repair pathway activation features in follicular and papillary thyroid tumors, interrogated using 95 experimental RNA sequencing profiles 2021 ·Heliyon ·(unknown), (unknown), Marianna Zolotovskaia, (unknown), (unknown), (unknown), (unknown), (unknown), Нуршат Гайфуллин, Maria Suntsova, Г. С. Захарова, (unknown), Daniil Nikitin, Andrew Garazha, Xinmin Li, (unknown), Alexei L. Drobyshev, (unknown), Maxim Sorokin, Anton Buzdin	15
10	Using proteomic and transcriptomic data to assess activation of intracellular molecular pathways 2021 ·Advances in protein chemistry and structural biology ·Anton Buzdin, Victor Tkachev, Marianna Zolotovskaia, Andrew Garazha, Sergei A. Moshkovskii, Nicolas Borisov, Нуршат Гайфуллин, Maxim Sorokin, Maria Suntsova	17
11	COVID-19–associated inhibition of energy accumulation pathways in human semen samples 2021 ·PubMed ·L.V. Adamyan, (unknown), (unknown), A.A. Stepanian, (unknown), (unknown), (unknown), Maxim Sorokin, Maria Suntsova, Alexei L. Drobyshev, Andrew Garazha, Anton Buzdin	8
12	RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer 2020 ·Molecular Case Studies ·Maxim Sorokin, Elena Poddubskaya, (unknown), (unknown), (unknown), (unknown), Daria Allina, Maria Suntsova, Victor Tkachev, Andrew Garazha, Marina Sekacheva, Anton Buzdin	26
13	Cancer gene expression profiles associated with clinical outcomes to chemotherapy treatments 2020 ·BMC Medical Genomics ·Nicolas Borisov, Maxim Sorokin, Victor Tkachev, Andrew Garazha, Anton Buzdin	22
14	Correction: Nikitin, D., et al. Retroelement—Linked Transcription Factor Binding Patterns Point to Quickly Developing Molecular Pathways in Human Evolution 2019 ·Cells ·(unknown), Andrew Garazha, Maxim Sorokin, Dmitry Penzar, Victor Tkachev, А. В. Марков, Нуршат Гайфуллин, Pieter Borger, (unknown), Anton Buzdin	2
15	Atlas of RNA sequencing profiles for normal human tissues 2019 ·Scientific Data ·Maria Suntsova, Нуршат Гайфуллин, Daria Allina, (unknown), Xinmin Li, Л. П. Менделеева, В. Л. Сурин, Anna Sergeeva, Pavel Spirin, Vladimir Prassolov, (unknown), Andrew Garazha, Maxim Sorokin, Anton Buzdin	78
16	RNA sequencing for research and diagnostics in clinical oncology 2019 ·Seminars in Cancer Biology ·Anton Buzdin, Maxim Sorokin, Andrew Garazha, (unknown), (unknown), Elena Poddubskaya, Marina Sekacheva, Ella Kim, Нуршат Гайфуллин, Alf Giese, (unknown), (unknown), Sergei A. Moshkovskii, (unknown)	56
17	Molecular pathway activation – New type of biomarkers for tumor morphology and personalized selection of target drugs 2018 ·Seminars in Cancer Biology ·Anton Buzdin, Maxim Sorokin, Andrew Garazha, Marina Sekacheva, Ella Kim, (unknown), Ye Wang, Xinmin Li, (unknown), Christian Hartmann, Amir Samii, Alf Giese, Nicolas Borisov	70
18	Friends-Enemies: Endogenous Retroviruses Are Major Transcriptional Regulators of Human DNA 2017 ·Frontiers in Chemistry ·Anton Buzdin, Vladimir Prassolov, Andrew Garazha	42
19	Molecular functions of human endogenous retroviruses in health and disease 2015 ·Cellular and Molecular Life Sciences ·Maria Suntsova, Andrew Garazha, (unknown), (unknown), Alex Zhavoronkov, Anton Buzdin	72
20	Characteristic patterns of microRNA expression in human bladder cancer 2013 ·Frontiers in Genetics ·(unknown), Alex Zhavoronkov, Andrew Garazha, S. A. Roumiantsev, Anton Buzdin	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact